Tag Archives: Battle

Government Circuit Choice Delays Non specific Osteoarthritis Medicate

“The CAFC concurred with the locale court finding that claim 12 of the ‘913 patent was nonobvious, and in this way certified the area court’s finding that Actavis’s non specific sedate encroached the ‘913 patent“      On October 9, the U.S. Court of Appeals for the Government Circuit (CAFC) issued a decision in HZNP Medicines LLC v. Actavis Research facilities UT, Inc. certifying the U.S. Locale Court for the Area of Modern Jersey’s discoveries of weakness and non infringement of certain claims of a

Contact Us

Monday – Saturday: 9 am to 6 pm
Sunday: day off